Hans J. Woerle

Area of research

Endocrinology, Diabetes and Metabolism · Surgery

Research interest

Research interests include Empagliflozin, Medicine, Internal medicine, Hazard ratio, Myocardial infarction, and Heart failure.

h-index

—

citations

12,883

works

NIH funding

—

primary concept

—

✉ Find email ↗

Recent publications

The effect of empagliflozin on muscle sympathetic nerve activity in patients with type II diabetes mellitus

Journal of the American Society of Hypertension 2017cited by 97position: middledoi

Heart failure outcomes with empagliflozin in patients with type 2 diabetes at high cardiovascular risk: results of the EMPA-REG OUTCOME <sup>®</sup> trial

European Heart Journal 2016cited by 900position: middledoi

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

New England Journal of Medicine 2015cited by 11,886position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Uli C. Broedl · George Washington University3 papers (2015–2017)Christoph Wanner · Smart Material (Germany)3 papers (2015–2017)Silvio E. Inzucchi · Yale University2 papers (2015–2016)— · 2 papers (2015–2016)Odd Erik Johansen · Société d'Étude de l'Environnement (Switzerland)2 papers (2015–2016)John M. Lachin · Milken Institute2 papers (2015–2016)David Fitchett · St. Michael's Hospital2 papers (2015–2016)Michaela Mattheus · George Washington University2 papers (2015–2017)Bernard Zinman · Lunenfeld-Tanenbaum Research Institute2 papers (2015–2016)Erich Bluhmki · University of Edinburgh1 papers (2015–2015)Jens Jordan · Medizinische Hochschule Hannover1 papers (2017–2017)— · 1 papers (2017–2017)Karsten Heusser · Medizinische Hochschule Hannover1 papers (2017–2017)Tim Heise · Profil Institute for Metabolic Research1 papers (2017–2017)Afshin Salsali · Universitätsklinikum Würzburg1 papers (2016–2016)Martina Heer · University Hospital Frankfurt1 papers (2017–2017)Jens Tank · Medizinische Hochschule Hannover1 papers (2017–2017)— · 1 papers (2015–2015)— · 1 papers (2017–2017)